According to Regeneron Pharmaceuticals's latest financial reports the company's current earnings are โฌ13.84 Billion. In 2023 the company made an earning of โฌ3.99 Billion a decrease over its 2022 earnings that were of โฌ4.62 Billion. The earnings displayed on this page is the company's Pretax Income.